800 related articles for article (PubMed ID: 8808691)
1. RB1 oncosuppressor gene over-expression inhibits tumor progression and induces melanogenesis in metastatic melanoma cells.
Valente P; Melchiori A; Paggi MG; Masiello L; Ribatti D; Santi L; Takahashi R; Albini A; Noonan DM
Oncogene; 1996 Sep; 13(6):1169-78. PubMed ID: 8808691
[TBL] [Abstract][Full Text] [Related]
2. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines.
Muncaster MM; Cohen BL; Phillips RA; Gallie BL
Cancer Res; 1992 Feb; 52(3):654-61. PubMed ID: 1732054
[TBL] [Abstract][Full Text] [Related]
3. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
4. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress.
Baldi A; Lombardi D; Russo P; Palescandolo E; De Luca A; Santini D; Baldi F; Rossiello L; Dell'Anna ML; Mastrofrancesco A; Maresca V; Flori E; Natali PG; Picardo M; Paggi MG
Clin Cancer Res; 2005 May; 11(9):3175-83. PubMed ID: 15867210
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1.
Hazarika P; McCarty MF; Prieto VG; George S; Babu D; Koul D; Bar-Eli M; Duvic M
Cancer Res; 2004 Oct; 64(20):7361-9. PubMed ID: 15492257
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
7. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
8. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
[TBL] [Abstract][Full Text] [Related]
9. Integrin beta 3 cDNA transfection into a highly metastatic alpha v beta 3-negative human melanoma cell line inhibits invasion and experimental metastasis.
Danen EH; van Kraats AA; Cornelissen IM; Ruiter DJ; van Muijen GN
Biochem Biophys Res Commun; 1996 Sep; 226(1):75-81. PubMed ID: 8806594
[TBL] [Abstract][Full Text] [Related]
10. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
11. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
12. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
Wu GJ; Fu P; Wang SW; Wu MW
Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of novel protein kinase C delta in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo.
La Porta CA; Di Dio A; Porro D; Comolli R
Melanoma Res; 2000 Apr; 10(2):93-102. PubMed ID: 10803709
[TBL] [Abstract][Full Text] [Related]
15. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
[TBL] [Abstract][Full Text] [Related]
16. Anti-cell death activity promotes pulmonary metastasis of melanoma cells.
Takaoka A; Adachi M; Okuda H; Sato S; Yawata A; Hinoda Y; Takayama S; Reed JC; Imai K
Oncogene; 1997 Jun; 14(24):2971-7. PubMed ID: 9205104
[TBL] [Abstract][Full Text] [Related]
17. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells.
Kurisu S; Suetsugu S; Yamazaki D; Yamaguchi H; Takenawa T
Oncogene; 2005 Feb; 24(8):1309-19. PubMed ID: 15608687
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
Guba M; Bosserhoff AK; Steinbauer M; Abels C; Anthuber M; Buettner R; Jauch KW
Br J Cancer; 2000 Nov; 83(9):1216-22. PubMed ID: 11027436
[TBL] [Abstract][Full Text] [Related]
19. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
[TBL] [Abstract][Full Text] [Related]
20. Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
Kim A; Jung JY; Son M; Lee SH; Lim JS; Chung AS
Oncol Rep; 2008 Sep; 20(3):557-65. PubMed ID: 18695906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
